Programme pricing
Clear pricing. Ongoing medical care.
Your monthly programme price depends on the treatment strength prescribed by your clinician.
Monthly programme price by prescribed strength
For information only. Strengths cannot be selected.
- 2.5 mg
- £315/month
- 5 mg
- £330/month
- 7.5 mg
- £385/month
- 10 mg
- £405/month
- 12.5 mg
- £425/month
- 15 mg
- £445/month
Your treatment and strength are determined by your prescribing clinician based on clinical suitability, response and individual circumstances.
Treatment may change according to clinical assessment, response and tolerability.
Prescription treatment is not guaranteed following assessment.
What your monthly programme is intended to include
- Clinical assessment and review
- Ongoing prescribing review
- Treatment where prescribed
- Scheduled clinical reviews
- Blood-test provision
- Ongoing monitoring
- Treatment consumables where required
- Appropriate delivery packaging
- UK delivery
- Patient support
Inclusions depend on the final clinical pathway and your individual clinical requirements.
Your treatment and strength are determined by your prescribing clinician based on clinical suitability, response and individual circumstances. Prescription treatment is not guaranteed following assessment. Strengths shown are for information only and cannot be selected.
Patient journey
What your programme looks like over time
Indicative timings. Individual circumstances may require different timing.
- 1
Online assessment
Complete your medical questionnaire and provide the information required for clinical review.
- 2
Clinical review
Your medical information is reviewed by the appropriate clinician.
- 3
Treatment decision
The clinician determines the appropriate next step for you.
- 4
Treatment begins where prescribed
Where clinically appropriate, treatment is prescribed and dispensed through the agreed clinical pathway.
- 5
First blood monitoring
Blood collection at home or at the London clinic during the early treatment period.
- 6
Clinical review at approximately 4 weeks
A booked video consultation to review progress, response and tolerability.
- 7
Further review approximately 10 weeks later
Your next scheduled clinical review, arranged with you in advance.
- 8
Continued clinical monitoring
Reviews, prescribing review and support continue throughout your programme.
- 9
Repeat blood monitoring
Approximately six months after your first blood test, subject to clinical requirements.